FDA NDC
OGIVRI
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 83257-001
- Proprietary name
- OGIVRI
- Nonproprietary name
- trastuzumab-dkst
- Labeler
- Biocon Biologics Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Strength
- 150 mg/7.4mL
HCPCS Q5100 Billable units per 11-digit NDC: 90.